Association Between the Frailty Index and Clinical Outcomes after Coronary Artery Bypass Grafting

Chan Hyeong Kim1, Yoonjin Kang1, Ji Seong Kim1

  • 1Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Insights

The frailty index (FI-L), using lab data and vital signs, predicts mortality and complications after coronary artery bypass grafting (CABG). A 32% FI-L cutoff identifies high-risk patients for improved outcomes.

Area of Science:

  • Cardiology
  • Geriatrics
  • Surgical Outcomes

Background:

  • Coronary artery bypass grafting (CABG) is a major surgery with significant risks.
  • Assessing patient frailty preoperatively is crucial for predicting surgical outcomes.
  • Traditional frailty assessments may not fully capture physiological status.

Purpose of the Study:

  • To evaluate the predictive value of the frailty index calculated using laboratory data and vital signs (FI-L) in CABG patients.
  • To determine the association of FI-L with mortality and postoperative complications following CABG.
  • To identify an optimal FI-L cutoff for predicting adverse events post-CABG.

Main Methods:

  • A cohort of 508 patients undergoing CABG between 2018-2021 was analyzed.
  • The frailty index (FI-L) was computed using 32 preoperative laboratory and vital sign parameters.
  • Primary endpoints included operative and medium-term all-cause mortality; secondary endpoints were postoperative complications and MACCEs.

Main Results:

  • The mean FI-L was 20.9%. Early mortality was 1.6%. Common complications included atrial fibrillation (29.1%) and respiratory issues (7.5%).
  • Higher FI-L was significantly associated with medium-term all-cause mortality (HR 1.042), MACCEs (sHR 1.054), atrial fibrillation (OR 1.02), acute kidney injury (OR 1.06), and re-operation for bleeding (OR 1.09).
  • A 32% FI-L cutoff was identified as optimal for predicting all-cause mortality post-CABG.

Conclusions:

  • The FI-L is a significant prognostic factor in patients undergoing CABG.
  • FI-L effectively predicts medium-term all-cause mortality and various postoperative complications.
  • This index offers a valuable tool for risk stratification in CABG patients.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
48
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
67
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
86
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
60
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
61